← Back to Search

Other

SRX246 for Anxiety

Phase 1
Waitlist Available
Research Sponsored by Azevan Pharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 7 days
Awards & highlights

Study Summary

To determine the effects of SRX246 on fear and anxiety based on fear-potentiated startle in humans. Additionally, the effects of the compound on emotion recognition will be explored.

Eligible Conditions
  • Anxiety

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in startle reflex between SRX246 and Placebo
Secondary outcome measures
Change in State Anxiety Scale between SRX246 and Placebo
Change in emotional expression recognition between SRX246 and Placebo

Side effects data

From 2016 Phase 1 & 2 trial • 97 Patients • NCT02055638
6%
Headache
6%
Diarrhea
6%
Dry Mouth
100%
80%
60%
40%
20%
0%
Study treatment Arm
SRX246
Placebo

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: SRX246Experimental Treatment1 Intervention
SRX246 oral dosage capsules, daily dose to be taken bid, for up to 7 days
Group II: PlaceboPlacebo Group1 Intervention
Placebo oral dosage capsules, daily dose to be taken bid, for up to 7 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SRX246
2009
Completed Phase 2
~280

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Azevan PharmaceuticalsLead Sponsor
7 Previous Clinical Trials
436 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,781 Previous Clinical Trials
2,674,942 Total Patients Enrolled
82 Trials studying Anxiety
39,064 Patients Enrolled for Anxiety

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans
2017. "Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02922166.
All > Anxiety > Experimental
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top